These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1711064)

  • 1. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
    Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
    J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology.
    Trinchet JC; Hartmann DJ; Pateron D; Munz-Gotheil C; Callard P; Ville G; Beaugrand M
    Alcohol Clin Exp Res; 1992 Apr; 16(2):342-6. PubMed ID: 1590556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
    Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
    Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procollagen III and laminin in chronic viral hepatopathies].
    Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
    Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
    McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
    Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
    Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
    Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease.
    Weigand K; Zaugg PY; Frei A; Zimmermann A
    Hepatology; 1984; 4(5):835-8. PubMed ID: 6479852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
    Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
    Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
    Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
    Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.
    Morelli A; Vedovelli A; Fiorucci S; Angelini GP; Fini C; Palmerini CA; Floridi A
    Clin Chim Acta; 1985 May; 148(2):87-95. PubMed ID: 3888456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha.
    Hiramatsu N; Hayashi N; Kasahara A; Hagiwara H; Takehara T; Haruna Y; Naito M; Fusamoto H; Kamada T
    J Hepatol; 1995 Feb; 22(2):135-42. PubMed ID: 7790701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
    Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
    Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
    Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
    Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
    Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
    Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
    Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
    Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
    Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
    García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.